Adam R. Glassman

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

Michael J. Elman, Lloyd Paul Aiello, Roy W. Beck et al. · Ophthalmology · 2010 · 1.4K citations · Full text

Diabetic Retinopathy, Ocular Disease, Vitreous Body +7

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology · 2016 · 982 citations · Full text

Diabetic Retinopathy, Ocular Disease, Ophthalmology +4

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA · 2015 · 743 citations

Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema

David J. Browning, Adam R. Glassman, Lloyd Paul Aiello et al. · Ophthalmology · 2006 · 601 citations · Full text

Diabetic Retinopathy, Ocular Disease, Retina +6

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

Michael J. Elman, Neil M. Bressler, Haijing Qin et al. · Ophthalmology · 2011 · 568 citations · Full text

Ranibizumab Plus Prompt, Diabetic Retinopathy, Ocular Disease +7